Literature DB >> 698569

Drugs for myeloma.

J S Malpas, D Parker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 698569      PMCID： PMC1607016          DOI： 10.1136/bmj.2.6136.563

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.

Authors:  D C Case; D J Lee; B D Clarkson
Journal:  Am J Med       Date:  1977-12       Impact factor: 4.965

2.  Combination therapy for multiple myeloma.

Authors:  R Alexanian; S Salmon; J Bonnet; E Gehan; A Haut; J Weick
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

3.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.